Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,428 | 29,813 | 32,494 | 34,056 | 37,219 |
| Receivables | 890 | 550 | 1,207 | 956 | 716 |
| TOTAL | $29,091 | $32,205 | $35,761 | $37,236 | $40,178 |
| Non-Current Assets | |||||
| PPE Net | 271 | 252 | 305 | 338 | 342 |
| Other Non-Current Assets | 1,897 | 157 | 213 | 267 | 320 |
| TOTAL | $2,168 | $409 | $518 | $605 | $662 |
| Total Assets | $31,259 | $32,614 | $36,279 | $37,841 | $40,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,022 | 1,806 | 1,421 | 2,937 | 976 |
| TOTAL | $3,262 | $1,924 | $1,587 | $3,145 | $1,216 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,613 | 0 | 10 | 27 | 57 |
| TOTAL | $1,613 | $N/A | $10 | $27 | $57 |
| Total Liabilities | $4,875 | $1,924 | $1,597 | $3,172 | $1,273 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,174 | 10,174 | 10,174 | 10,174 | 8,143 |
| Common Shares | 10 | 10 | 10 | 8 | 8 |
| Retained earnings | -315,914 | -311,450 | -307,285 | -303,119 | -297,930 |
| TOTAL | $26,384 | $30,690 | $34,682 | $34,669 | $39,567 |
| Total Liabilities And Equity | $31,259 | $32,614 | $36,279 | $37,841 | $40,840 |